title: Are the anticardiolipin antibodies a risk factor for coronary artery disease in chronic renal failure patients?
abstract: OBJECTIVE
  It has been proposed that anticardiolipin (aCL) antibodies are a risk factor for coronary artery disease (CAD) in recently studies. In this study, we aimed to investigate the existence of coronary artery disease in dialysis patients who were aCL positive and undergoing hemodialysis and peritoneal dialysis due to end stage renal failure and also to determine its relationship with risk factors in patients with coronary artery disease.
  
  
  METHODS
  This study has been conducted in the end stage renal failure in 140 hemodialysis patients, 18 peritoneal dialysis patients, and 38 healthy controls. The urea, creatinine, total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride, total protein, and albumin values are obtained. In all cases, aCL levels are investigated with ELISA method.
  
  
  RESULTS
  In the HD and CAPD patients, no significant relationship could be found between the age, gender, dialysis time, total cholesterol, HDL cholesterol, LDL cholesterol, total protein, and albumin values (p > 0.05). HD and CAPD vs. controls (aCL), 9.2% (13/140), 11.1% (2/18) vs. 2.6% (1/38), p = 0.002. No significant difference was noted between aCL-positive and -negative patients in serum urea, creatinine, total cholesterol, HDL cholesterol, LDL cholesterol, triglyceride, total protein, and albumin levels. The coronary artery disease was determined in three patients out of 16 patients with aCL positivity.
  
  
  CONCLUSIONS
  The prevalence of aCL antibodies positivity in our study was similar to the prevalence of aCL positivity in other studies. Therefore, we do not think aCL antibodies positivity is a risk factor for coronary artery disease.
authors.affiliation: Department of Internal Medicine, Mustafa Kemal University Faculty of Medicine, Hatay, Turkey.
authors.forename: Edip
authors.initials: E
authors.lastname: Ucar
authors.forename: Guven
authors.initials: G
authors.lastname: Kuvandik
authors.forename: Mehmet
authors.initials: M
authors.lastname: Sert
authors.forename: Ceren
authors.initials: C
authors.lastname: Kuvandik
authors.forename: Aysegul
authors.initials: A
authors.lastname: Temizkan
authors.forename: Ali
authors.initials: A
authors.lastname: Borazan
mesh_terms: D000328:Adult; D017153:Antibodies, Anticardiolipin / Q000097:blood*; D003324:Coronary Artery Disease / Q000209:etiology*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000150:complications / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis; D012307:Risk Factors
chemical_list: D017153:Antibodies, Anticardiolipin